Shannon M. Parisotto
Known title: CEVP, Disc & Safety AssessmentCIK: 0001952784
Associated companies
Transaction History
| CRL | ▲ Buy | Option Exercise | 981 | $204K | 10/5/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 981 | $303K | 10/5/2026 | View on chart |
| CRL | ▲ Buy | Option Exercise | 2,039 | $396K | 8/19/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 2,039 | $600K | 8/19/2026 | View on chart |
| CRL | ▲ Buy | Option Exercise | 3,714 | $667K | 8/11/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 3,714 | $1.0M | 8/11/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 5,046 | $1.3M | 8/5/2026 | View on chart |
| CRL | ▼ Sell | Gift | 1,529 | $0 | 6/5/2026 | View on chart |
| CRL | ▼ Sell | Gift | 1,529 | $0 | 6/5/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 170 | $31K | 5/31/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 551 | $100K | 5/30/2026 | View on chart |
| CRL | ▲ Buy | Grant | 4,361 | $788K | 5/29/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 105 | $16K | 5/27/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 168 | $27K | 5/26/2026 | View on chart |
| CRL | ▼ Sell | Gift | 7,169 | $0 | 2/6/2026 | View on chart |
| CRL | ▼ Sell | Gift | 7,169 | $0 | 2/6/2026 | View on chart |
| CRL | ▲ Buy | Grant | 4,236 | $0 | 1/30/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 1,067 | $226K | 1/30/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 105 | $14K | 5/31/2025 | View on chart |
| CRL | ▲ Buy | Grant | 5,603 | $760K | 5/30/2025 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 44 | $6K | 5/28/2025 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 65 | $9K | 5/27/2025 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 104 | $14K | 5/26/2025 | View on chart |
| CRL | ▲ Buy | Grant | 1,758 | $0 | 1/31/2025 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 471 | $78K | 1/31/2025 | View on chart |
| CRL | ▲ Buy | Grant | 1,727 | $0 | 5/31/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 110 | $24K | 5/29/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 70 | $15K | 5/28/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 105 | $23K | 5/27/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 168 | $36K | 5/26/2024 | View on chart |
| CRL | ▼ Sell | Gift | 412 | $0 | 3/1/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 3,686 | $934K | 2/29/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 100 | $25K | 2/29/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 610 | $147K | 2/15/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 1,617 | $388K | 2/15/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 632 | $153K | 2/15/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 604 | $147K | 2/15/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 749 | $183K | 2/15/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 89 | $22K | 2/15/2024 | View on chart |
| CRL | ▲ Buy | Option Exercise | 5,882 | $851K | 2/15/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 291 | $69K | 2/15/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 1,290 | $309K | 2/15/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 555 | $122K | 1/29/2024 | View on chart |
| CRL | ▲ Buy | Grant | 2,115 | $0 | 1/29/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 110 | $21K | 5/29/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 71 | $14K | 5/28/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 105 | $20K | 5/27/2023 | View on chart |
| CRL | ▲ Buy | Grant | 1,700 | $0 | 5/26/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 136 | $33K | 2/22/2023 | View on chart |
| CRL | ▼ Sell | Open Market | 155 | $40K | 2/16/2023 | View on chart |
| CRL | ▲ Buy | Option Exercise | 4,558 | $498K | 2/16/2023 | View on chart |
| CRL | ▼ Sell | Open Market | 116 | $29K | 2/16/2023 | View on chart |
| CRL | ▼ Sell | Open Market | 194 | $48K | 2/16/2023 | View on chart |
| CRL | ▼ Sell | Open Market | 158 | $40K | 2/16/2023 | View on chart |
| CRL | ▼ Sell | Open Market | 1,674 | $428K | 2/16/2023 | View on chart |
| CRL | ▼ Sell | Open Market | 994 | $255K | 2/16/2023 | View on chart |
| CRL | ▼ Sell | Open Market | 19 | $5K | 2/16/2023 | View on chart |
| CRL | ▼ Sell | Open Market | 264 | $67K | 2/16/2023 | View on chart |
| CRL | ▼ Sell | Open Market | 451 | $114K | 2/16/2023 | View on chart |
| CRL | ▼ Sell | Open Market | 533 | $136K | 2/16/2023 | View on chart |
| CRL | ▲ Buy | Grant | 4,820 | $0 | 1/27/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 1,309 | $320K | 1/27/2023 | View on chart |
| CRL | ▲ Buy | Option Exercise | 2,279 | $249K | 11/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 2,279 | $570K | 11/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
CRL Analyst Targets Rise After UBS Reinstates Coverage
Charles River Laboratories saw its average analyst price target increase to $305.00, driven by UBS reinstating coverage with a $357.00 target. This move follows reports of stabilizing demand and increased interest in animal model markets. The stock is currently trading below its 52-week high, with technical indicators showing support near $181.76.
CRL Analyst Targets Rise After UBS Reinstates Coverage. Charles River Laboratories saw its average analyst price target increase to $305.00, driven by UBS reinstating coverage with a $357.00 target. This move follows reports of stabilizing demand and increased interest in animal model markets. The stock is currently trading below its 52-week high, with technical indicators showing support near $181.76.